Voluntary Health Associations & Medical Disciplines
Epilepsy Study Consortium Inc
HERNDON, VA
Total revenue
$2.5M
Total expenses
$2.2M
Net assets
$3.7M
Grants received
$35K
2 grants
EIN
204950952
Tax year
2024
Mission
Accelerating the development of new therapies in epilepsy to improve patient care through research.
Programs
2 programs
Human epilepsy project - continuing to analyze data from hep 1 & heps 2 studies. Oversee and coordinate the financial aspects of the hep3 study. Tesc manages hep3 studys life cycle for nyu, oversees and coordinates financial aspects of the study and the participating sites.
Trial designs - prepare and organize multinational symposium on epilepsy trial design and implementation.
Financials
FY 2024
Revenue
Expenses
People
16 listed
BREE DIVENTURA
CO-EXECUTIVE DIRECTOR
$234K
40 hrs/wk
MERYL J LOZANO
CO-EXECUTIVE DIRECTOR
$150K
40 hrs/wk
MICHAEL GELFAND MD
DIRECTOR
$22K
1 hrs/wk
GREGORY KRAUSS MD
DIRECTOR
$5K
1 hrs/wk
MICHAEL SPERLING MD
DIRECTOR
$4K
1 hrs/wk
SUDHA KESSLER MD
DIRECTOR
—
1 hrs/wk
ROBERT WECHSLER MD PHD
DIRECTOR
—
1 hrs/wk
CLAUDE STERIADE MD
DIRECTOR
—
1 hrs/wk
JENNIE MINNICK
EXECUTIVE COMMITTEE MEMBER
—
1 hrs/wk
PAVEL KLEIN MD
DIRECTOR
—
1 hrs/wk
JACQUELINE FRENCH MD
PRESIDENT
—
5 hrs/wk
DENNIS DLUGOS MD
VICE PRESIDENT
—
1 hrs/wk
DANIEL FRIEDMAN MD
VICE PRESIDENT
—
1 hrs/wk
DAWN ELIASHIV MD
DIRECTOR
—
1 hrs/wk
JAMES LINTOTT ESQ
TREASURER
—
1 hrs/wk
TRACY L DE VITO
EMPLOYEE
$110K
40 hrs/wk
Grants received
Showing 2 of 2
Funded by
$35K from 2 funders · 2 grants · 2021–2023
$25K · 1 grant · 2023
$10K · 1 grant · 2021